US Department of Health and Human Services Raises Buprenorphine Cap from 100 to 275

July 21st, 2016

The American Society of Addiction Medicine highlights the policy change as an important step to help combat the current epidemic of opioid addiction and overdose deaths and urges the Department of Health and Human Services to evaluate the rule’s impact on treatment access, diversion, health care costs and clinical outcomes to inform future changes to the patient limit.

If you are a provider exploring your patient increase options, you may find this blog post written by Dr. Jana Burson helpful as she shared her initial thoughts regarding the patient increase proposal in May.

The final rule will be effective on August 5, 2016.

Posted in Content


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.